Aim: Glioma, with fast growth and progression features, is the most common and aggressive tumor in the central nervous system and is essentially incurable. This study is aimed at inducing neuronal differentiation to suppress glioma cell growth with a single transcription factor. 
| INTRODUC TI ON

Nobel Prize winner Yamanaka has used transcription factors to reprogram somatic cells into iPS cells in 2006,
1 which led to a series of improved methods of cell reprogramming, including the direct reprogramming of somatic cells into other tissue cells. [2] [3] [4] Glioma is a malignant disease with a high incidence 5 and a very poor prognosis. 6, 7 It still lacks effective treatment strategies 8, 9 and seriously endangers human health. Can glioma be treated with cell reprogramming? In order to find out the answer, we began to explore key transcription factors that affect the development of the nervous system.
ZIC1 gene encodes a zinc finger protein, and almost all Zic1-deficient mice die within a month, with cerebellum dysplasia. 10 Zic1/ Zic3 complex mutant mice have abnormal forebrain, and lack of Zic1 and Zic3 leads to hippocampus, septum, and olfactory bulb hypoplasia. 11 Zic1, expressed at the anterior neural plate, can regulate the synthesis and transport of retinoic acid and is sufficient and necessary to promote placode fate. 12 Zic1 silencing prevents the differentiation of mouse embryonic stem cells into neuron precursors. 13 ZIC1 has tumor suppressive effects in breast cancer, 14 thyroid cancer, 15 gastric cancer, 16, 17 colon cancer, 18 and malignant pleural mesothelioma. 19 However, the role of ZIC1 in glioma is unknown.
Sox11 can reprogram adult optic ganglion cells to a state with sufficient growth capacity, thereby promoting the regeneration of certain types of optic ganglion neurons. 20 NEUROG2 and SOX11
synergistically convert human glioma cells into terminally differentiated neuron-like cells in vitro and in adult mouse brain.
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These two transcription factors can also convert healthy and patient postnatal and adult skin fibroblasts into cholinergic neurons. 22 Whether ZIC1 has cell reprogramming ability has not been reported.
From the above-mentioned findings, we know that ZIC1 and SOX11 have a very important role in neuronal development and tumor suppression. However, the relationship between them has not been fully clarified, and there is also no research using ZIC1 for cell reprogramming. Therefore, we used glioma cells to explore the relationship between SOX11 and ZIC1, revealing that similar to SOX11, ZIC1 can also transdifferentiate U87 cells into neuron-like cells.
Furthermore, ZIC1 is a target gene of SOX11, and SOX11 upregu- XhoI to replace the CMV promoter on the lentiviral vector pLVXmCherry-N1 (Clontech) ( Figure 4A ). The primers used to amplify ZIC1
promoter are as follows (Table 1) , 2487 bp (ClaI-ZIC1 promoter-F and XhoI-ZIC1 promoter-R), 205 bp (ClaI-ZIC1 promoter-F and XhoI-ZIC1
promoter-R3), 232 bp (ClaI-ZIC1 promoter-F4 and XhoI-ZIC1 promoter-R4), 1248 bp (ClaI-ZIC1 promoter-F2 and XhoI-ZIC1 promoter-R2), 1270 bp (ClaI-ZIC1 promoter-F and XhoI-ZIC1 promoter-R5), and 1219 bp (ClaI-ZIC1 promoter-F3 and XhoI-ZIC1 promoter-R). 
| Cell cultures
| Lentivirus transfection
Lentivirus production was described as previous. 23 Briefly, lentivirus vector and lentivirus packaging vectors psPAX2 and pMD2.G were cotransfected into HEK293T cells through calcium phosphate-DNA coprecipitation. For infection, cells were incubated with viral supernatant at 37°C overnight, and then, medium was replaced with fresh medium.
| ZIC1 KO cell lines construction
After ZIC1 KO lentivirus infection for 48 hours and puromycin selection for 48 hours. Cells were trypsinized and counted, and then 100 μL of medium containing about four cells was added into each well of a 96-well plate. Cells will be observable via microscopy over 3 days and be ready to score in 8 days.
Mark each well on the cover of the plate indicating which well contains a single colony. These colonies can later be subcultured from the wells into larger vessels. Finally, U87-ZIC1-KO#1 and U87-ZIC1-KO#2 cell lines were identified by Sanger sequencing with primers CACGTCGGCTCCTATTCCA and CCTCCCAGAAGCAGATGTGATTACTC, respectively.
| Flow cytometry
Cells were passaged to 6-well plate for 2 × 10 5 cells/well. Six hours later, these cells were infected with virus supernatant (fresh medium:
virus supernatant = 1 mL: 0.4 mL), and 24 hours later, repeat infection again. Forty-eight hours later, replace medium with 2 mL fresh medium. Seventy-two hours later, after harvesting and centrifugation, the supernatant was removed and the cell pellet was washed once with PBS. Cell cycle and annexin V-APC apoptosis detection protocols can be found on the KeyGEN product information home page.
Tested with BD FACSVerse and analyzed using FlowJo software.
| Microarray gene expression analysis
After infection with control and SOX11 lentivirus, total RNA was extracted from U87 cells. After total RNA samples were analyzed by Agilent 2100 (Agilent, Santa Clara, CA, USA), aRNA (amplified RNA) was prepared using GeneChip 3′IVT Express Kit (Affymetrix, Santa Clara, CA, USA). That is, cDNA is synthesized by one-strand synthesis, and a double-stranded DNA template is further obtained by two-strand synthesis, and then an avidin-labeled aRNA (amplified RNA) is obtained by in vitro inversion. The aRNA is purified and then fragmented and hybridized with the chip probe. After the hybridization is completed, the chip is washed and dyed, and the image and original data are finally scanned.
| mRNA extraction and qRT-PCR
Total RNA was isolated by using the RNAprep Pure Cell/Bacteria Kit (Tiangen, Beijing, China), and RNA concentration was determined by Nano-300 (Allsheng, Hangzhou, China). 500 ng of total RNA from each sample was reverse transcribed into cDNA using HiScript II Q RT SuperMix for qPCR (+gDNA wiper; Vazyme, Nanjing, China) and subjected to qRT-PCR (ABI 7500, Thermo) using the ChamQ SYBR qPCR Master Mix (Low ROX Premixed; Vazyme). GAPDH serves as an internal reference in gene expression analysis. ChIP-qPCR was performed according to the manufacturer's instructions (Beyotime, #P2078, Beijing, China). Primers sequences are as follows ( Table 2 ).
| Immunocytochemistry and imaging
Immunofluorescent staining was described previously. 24 We stained 
| Western blotting
Nontargeting control and ZIC1 KO cell lines were collected and lysed in RIPA buffer. Protein concentrations were calculated with the BCA kit (Tiangen). After denaturing, 30 μg of total proteins was subjected indicates cells within S phase, and red indicates cells within G2/M phase. Statistical difference was accepted when P < 0.05 compared to control. **P < 0.01, ***P < 0.001. (C) FACS revealed that ectopic SOX11 significantly promoted cell apoptosis 3 days after virus infection. Statistical difference was accepted when P < 0.05 compared to control. **P < 0.01. (D) Immunofluorescence staining of control and SOX11 overexpression cells with MAP2, TUBB3, SOX11, and ZIC1 primary antibodies, respectively. MAP2, TUBB3, and ZIC1 co-expressed with SOX11 (indicated in red channel). MAP2 and TUBB3 are expressed in cytoplasm, SOX11 is only expressed in the nuclei, and ZIC1 is expressed both in nuclei and cytoplasm. Data were obtained from 10 randomly selected fields from triplicate samples to SDS-PAGE. Antibodies used were ZIC1 (1:1000, rabbit IgG; Abcam) and ACTB (1:5000, mouse IgG, CST, Danvers, MA, USA).
TA B L E 2 Primer oligonucleotides used for qPCR
| Gene expression profiling interactive analysis
SOX11 and ZIC1 gene expression correlation analysis and overall survival analysis based on MAP2 gene expression for given sets of TCGA expression data are performed by GEPIA.
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| Statistical analyses
All experiments were carried out in triplicates and repeated separately at least three times. Student's t tests were used to measure significance between control and the experiment groups. Data were analyzed by Excel (Microsoft, Redmond, WA, USA). The tests were performed with a nominal significant level of 0.05. *P < 0.05, **P < 0.01, and ***P < 0.001. Results were shown as mean ± SEM.
| RE SULTS
| SOX11 inhibits cell proliferation and induces neuronal differentiation
After overexpression of SOX11 for 3 days, the proliferation of U87, U251, and A172 cells was significantly slower than that of the control group, and even there were many floating dead cells ( Figure 1A ). 
WB (E), qRT-PCR (F)
, and Sanger sequencing (G) were used to detect ZIC1 knockout effects of U87-ZIC1-KO#1 and U87-ZIC1-KO#2, respectively. (H) ZIC1 deficiency resulted in significant suppression of SOX11-induced upregulation of MAP2 and TUBB3 expression. Statistical difference was accepted when P < 0.05 compared to control. **P < 0.01, ***P < 0.001
Then, the cells were tested by cell cycle and apoptosis detection. Cell cycle detection revealed that, compared to the control group, SOX11 overexpression resulted in a significant increase in G0/G1 phase and a significant decrease in G2/M phase, indicating that SOX11 overexpression can cause cell cycle in U87 cells to be arrested in the G0/ G1 phase, resulting in slower cell growth ( Figure 1B Interestingly, compared with controls, the 6 neural marker genes of SOX11 + cells were significantly upregulated in three independent GeneChips, including DCX, HES1, MAP2, NES, TUBB3, and ZIC1
| The neural induction function of SOX11 was confirmed by the results of GeneChip and qRT-PCR
( Figure 2C) . The results of qRT-PCR confirmed that the above six genes were indeed upregulated in SOX11 + cells, and the levels of TUBB3 and MAP2 were markedly increased ( Figure 2D ).
| As a downstream gene of SOX11, ZIC1 can also suppress cell growth and induce neuronal differentiation
Similar to SOX11, we also found that, after ZIC1 lentivirus infection for indicated days, the proliferation of ZIC1-overexpressing U87 cells was significantly inhibited, and a distinct neuron phenotype with elongated projections appeared ( Figure 3A) . Fluorescence-activated cell sorting (FACS) analysis also showed the cell cycle of ZIC1-overexpressing cells was arrested in G0/G1 phase compared with control ( Figure 3B ).
qRT-PCR revealed that DCX, HES1, MAP2, NES, and TUBB3
were significantly upregulated in ZIC1-overexpressing cells with TUBB3 increased the most ( Figure 3C ). Immunofluorescence results showed the elevated MAP2 and TUBB3 protein expression in ZIC1-overexpressing cells compared with control ( Figures 1D and 3D) , and SOX11 could not be detected, which revealed that SOX11 is not a downstream target of ZIC1 ( Figures 1D and 3D) .
The above results revealed that as a downstream gene of SOX11, ZIC1 well mimicked the function of SOX11 to suppress cell growth and promote neuronal differentiation of U87 cells.
| Downstream gene ZIC1 is crucial for neural induction of SOX11
To identify whether SOX11 protein can affect ZIC1 promoter 
| ZIC1 could be a potential tumor suppressor gene for gliomas treatment
The Cancer Genome Atlas (TCGA) correlation analysis revealed that there is a strong correlation between SOX11 and ZIC1 in TCGA lower grade glioma dataset (normalized by TUBB3; Figure 5A ). As a neuron-specific cytoskeletal protein, high MAP2 expression means better overall survival in TCGA lower grade glioma, indicating that the neuronal differentiation strategy of glioma cells induced by SOX11 or ZIC1 can be used as a feasible method for gliomas treatment ( Figure 5B ).
The relationship between SOX11 and ZIC1 and their neuronal induction function in glioma cells described above can be illustrated by 
| D ISCUSS I ON
Extremely rapid cell reproduction and progression are the primary cause of the fatality of human gliomas. In this study, we reported is also an immature neuron protein in the early development stages of neuron differentiation. 30 MAP2 is a neuron-specific cytoskeletal protein that is frequently applied as a mature neuron marker of general neuron phenotype, and its expression appears to be confined to neurons and reactive astrocytes. 31, 32 In this study, we have confirmed that SOX11 upregulates ZIC1 expression by binding with ZIC1
promoter and that various neural markers enriched in distinct neuron differentiation stages were highly expressed in SOX11-or ZIC1-overexpressed cells. Collectively, these data indicate that ZIC1 partially mediates the neuronal induction function of SOX11 in U87 cells.
| CON CLUS ION
Our study confirmed that ZIC1, a direct target gene of SOX11, can well mimic the role of SOX11 in promoting neuronal differentiation and suppress cell growth of glioma cells, suggesting that ZIC1 may be a potential target for glioma treatment. These data raise the feasibility of molecular and cellular biology methodologies to deliver new pharmacological tools for reprogramming pathway discovery that F I G U R E 6 The relationship between SOX11 and ZIC1 and their neuronal induction of glioma cells are illustrated can also act as checkpoints for differentiation agents combined with current standard therapies to treat different forms of gliomas.
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